Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily L Germain-Lee

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Pediatric Endocrinology & Metabolism : JPEM|April 21, 2015
Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophyMaria H Lin, Nawaporn Numbenjapon, Emily L Germain-Lee, et al.
JBMR Plus|January 26, 2022
Parental Origin of <i>Gsα</i> Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary OsteodystrophyPatrick McMullan, Peter Maye, Qingfen Yang, et al.
The Journal of Clinical Endocrinology and Metabolism|October 24, 2017
Ossifications in Albright Hereditary Osteodystrophy: Role of Genotype, Inheritance, Sex, Age, Hormonal Status, and BMIParissa Salemi, Julie M Skalamera Olson, Lauren E Dickson, et al.
Plos One|January 20, 2023
Prevalence of Chiari malformation type 1 is increased in pseudohypoparathyroidism type 1A and associated with aberrant bone developmentNeetu Krishnan, Patrick McMullan, Qingfen Yang, et al.
The Journal of Endocrinology|March 19, 2014
Potential biomarker of metformin actionLing He, Shumei Meng, Emily L Germain-Lee, et al.
Bone Research|July 11, 2015
Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfectaDouglas J DiGirolamo, Vandana Singhal, Xiaoli Chang, et al.
The Journal of Clinical Endocrinology and Metabolism|December 14, 2006
Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesityDominique N Long, Sarah McGuire, Michael A Levine, et al.
Pediatric Neurology|June 17, 2008
Central hypothyroidism and Sturge-Weber syndromeAnne M Comi, Sridevi Bellamkonda, Lisa M Ferenc, et al.
Current Diabetes Reports|August 16, 2016
Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with DiabetesScott J Pilla, Amy Q Quan, Emily L Germain-Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistanceEmily L Germain-Lee, Joshua Groman, Janet L Crane, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Pediatric Endocrinology & Metabolism : JPEM|April 21, 2015
Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophyMaria H Lin, Nawaporn Numbenjapon, Emily L Germain-Lee, et al.
JBMR Plus|January 26, 2022
Parental Origin of <i>Gsα</i> Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary OsteodystrophyPatrick McMullan, Peter Maye, Qingfen Yang, et al.
The Journal of Clinical Endocrinology and Metabolism|October 24, 2017
Ossifications in Albright Hereditary Osteodystrophy: Role of Genotype, Inheritance, Sex, Age, Hormonal Status, and BMIParissa Salemi, Julie M Skalamera Olson, Lauren E Dickson, et al.
Plos One|January 20, 2023
Prevalence of Chiari malformation type 1 is increased in pseudohypoparathyroidism type 1A and associated with aberrant bone developmentNeetu Krishnan, Patrick McMullan, Qingfen Yang, et al.
The Journal of Endocrinology|March 19, 2014
Potential biomarker of metformin actionLing He, Shumei Meng, Emily L Germain-Lee, et al.
Bone Research|July 11, 2015
Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfectaDouglas J DiGirolamo, Vandana Singhal, Xiaoli Chang, et al.
The Journal of Clinical Endocrinology and Metabolism|December 14, 2006
Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesityDominique N Long, Sarah McGuire, Michael A Levine, et al.
Pediatric Neurology|June 17, 2008
Central hypothyroidism and Sturge-Weber syndromeAnne M Comi, Sridevi Bellamkonda, Lisa M Ferenc, et al.
Current Diabetes Reports|August 16, 2016
Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with DiabetesScott J Pilla, Amy Q Quan, Emily L Germain-Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistanceEmily L Germain-Lee, Joshua Groman, Janet L Crane, et al.
Pageof 5